SMIM
2.685,61
PKT
-1,91
PKT
-0,07
%
Werbung
Analysen zu SMIM-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.03.12 | Adecco SA buy | ING | |
| 28.02.12 | PSP Swiss Property neutral | Sarasin Research | |
| 24.02.12 | Schindler neutral | UBS AG | |
| 23.02.12 | Roche overweight | J.P. Morgan Cazenove | |
| 22.02.12 | Straumann neutral | Sarasin Research | |
| 21.02.12 | Schindler buy | Sarasin Research | |
| 21.02.12 | Swatch (I) buy | Deutsche Bank AG | |
| 21.02.12 | Julius Bär buy | Sarasin Research | |
| 20.02.12 | Clariant buy | Citigroup Corp. | |
| 17.02.12 | EMS-CHEMIE buy | Sarasin Research | |
| 17.02.12 | Swatch (I) buy | Sarasin Research | |
| 16.02.12 | Clariant overweight | Barclays Capital | |
| 16.02.12 | Clariant sell | Société Générale Group S.A. (SG) | |
| 15.02.12 | Clariant buy | Sarasin Research | |
| 14.02.12 | Roche neutral | Citigroup Corp. | |
| 13.02.12 | Tecan (N) neutral | Sarasin Research | |
| 09.02.12 | Swatch (I) kaufen | Focus Money | |
| 08.02.12 | Swatch (I) buy | Société Générale Group S.A. (SG) | |
| 08.02.12 | Roche halten | Hamburger Sparkasse AG (Haspa) | |
| 08.02.12 | Swatch (I) buy | Sarasin Research | |
| 08.02.12 | Swatch (I) buy | Nomura | |
| 07.02.12 | Swatch (I) kaufen | Sarasin Research | |
| 07.02.12 | Julius Bär buy | Sarasin Research | |
| 06.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 03.02.12 | Roche outperform | Exane-BNP Paribas SA | |
| 03.02.12 | Roche overweight | Barclays Capital | |
| 02.02.12 | Roche neutral | Nomura | |
| 01.02.12 | Roche buy | Banc of America Securities-Merrill Lynch | |
| 01.02.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 01.02.12 | Roche buy | Sarasin Research | |
| 31.01.12 | Roche overweight | J.P. Morgan Cazenove | |
| 30.01.12 | Barry Callebaut sell | Société Générale Group S.A. (SG) | |
| 30.01.12 | SGS SA neutral | Sarasin Research | |
| 26.01.12 | Roche overweight | Barclays Capital | |
| 25.01.12 | Roche outperform | Exane-BNP Paribas SA | |
| 25.01.12 | SGS SA hold | Société Générale Group S.A. (SG) | |
| 24.01.12 | Roche buy | Deutsche Bank AG | |
| 23.01.12 | Roche overweight | Barclays Capital | |
| 20.01.12 | ams-OSRAM kaufen | Erste Bank AG | |
| 19.01.12 | Roche overweight | Barclays Capital |